MarketReportsOnline.com adds "Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19)" report to its research store.
Dallas, TX -- (SBWIRE) -- 02/02/2015 -- Spinal cord stimulation (SCS) is a pain relief technique that delivers a low-voltage electrical current continuously to the spinal cord to block the sensation of pain. SCS is the most commonly used implantable neuro-stimulation technology for management of pain syndromes. The growth of the global Spinal cord Stimulation market is driven by a number of factors that include rise in ageing demographics, rising healthcare expenditure per capita, growing cases of obesity and increasing number of failed surgeries. Acknowledging these factors, it could be said that the Spinal cord Stimulation market business will certainly gain importance in the years to come.
Complete report available at http://www.marketreportsonline.com/396022.html.
Segment Coverage: Rechargeable SCS System & Non-Rechargeable SCS system
Company Coverage: Boston Scientific, Nevro, St. Jude Medical & Medtronic
Strict regulations, environment issues, dearth of expertise and trained healthcare workers and several other issues pose major challenge to the growth of this business. Major trends prevailing in the spinal cord stimulation market are advancement in spine surgery, changing surgeon preferences, mergers & acquisitions and incidence of pain conditions in the US households.
The report titled "Global Spinal Cord Stimulation Market: Trends and Opportunities (2014-2019)" provides an in-depth analysis of the global Spinal cord Stimulation market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). Purchase a copy of this research report at http://www.marketreportsonline.com/contacts/purchase.php?name=396022.
The report also assesses the main types of SCS devices – the rechargeable and non-rechargeable spinal cord stimulation devices. Further, key players of the industry like Boston Scientific Corporation, St. Jude Medical and Medtronic have been profiled and analyzed in the report.
Other Related Reports on Pharmaceuticals Market:
Global Acne Treatment Market: Trends and Opportunities (2014-2019) (http://www.marketreportsonline.com/396023.html) The global acne market represents a small fraction of total dermatology market and both over the counter drugs and prescription drugs are used to treat acne. The acne market is primarily genericised and is moderately served by the currently marketed major prescribed drugs including SOLODYN, DORYX, and EPIDUO. The US market is the largest market for the global acne products with about 50 million suffering from acne in the country.
Global Biosimilar Market Trends & Opportunities: 2015 Edition (http://www.marketreportsonline.com/395635.html) This report analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report.
Further, key manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr. Reddy's Lab are profiled in the report.
US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition (http://www.marketreportsonline.com/395328.html) The PBM providers control drug spending and utilization by virtue of their advanced tools and techniques, encouraging use of generics and other lower-cost medications. In the US, there are some independent PBM's while some are owned by managed care organizations and retail pharmacies. Today, the PBM industry has become more determined through a series of mergers and acquisitions.
The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019) (http://www.marketreportsonline.com/376611.html) Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating. The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine.
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441